Sales Growth YoY (Last 12 Months): immixbio.com (IMMX)

Public company logo of immixbio.com (IMMX)

The development of T-cell therapies to combat solid tumors laid the foundation for growth, and the comparable year-over-year sales growth over 12 months on GURU.Markets reflects this peak. Subsequently, Immix Biopharma, Inc. (IMMX) established the IMX-110 ecosystem with hospital hubs, and the parameter stabilized at 0.00. Currently, Immix Biopharma, Inc. (IMMX) is implementing cultivation automation to eliminate defects in the production of CAR-T therapies.

Immix (IMMX) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 11/18/2026

Immix Biopharma, Inc. (IMMX) - metric breakdowns and financial figures

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Summary company analytics:Immix Biopharma, Inc.
Product sample of Immix

This indicator measures revenue dynamics over a rolling twelve-month period, capturing the daily growth rate of income. Analyzing this metric helps avoid purchasing overvalued assets by identifying the gap between market price and actual operational growth. By examining the trailing twelve months (TTM) growth of operating sales revenue, an investor can gauge the effectiveness of commercializing developments. For Immix Biopharma, Inc. (IMMX), such dynamics confirm the return on retaining an elite staff of immunologists. The cohesion of the scientific team converts directly into the stability of the company's financial performance.

Competitors of Immix Biopharma, Inc. (IMMX)

Sales Growth YoY (TTM) NantKwest IBRX|IMCR - Sales Growth YoY (Last Twelve Months)|JANX (januxrx.com) - Sales Growth YoY (Last 12 Months)|Arcus Corp (RCUS) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Zymeworks Corp (ZYME)|Revenue Growth YoY (Last 12 Months) TNGX|IOVA - Revenue Growth Rate YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) IMTX (Immatics Corp)|Revenue Change YoY (Last 12 Months) XNCR|Sales Growth YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Revenue Dynamics YoY (Last Twelve Months) REPL|lyell.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Innate Pharma S.A|Pyxis (PYXS) - Sales Growth YoY (Last Twelve Months)|Compugen Ltd - Revenue Dynamics YoY (Last Twelve Months)|IOBT (iobiotech.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) Sutro Biopharma Inc.|Sales Growth YoY (Last Twelve Months) MiNK Therapeutics (INKT)|HOWL: Trailing Twelve Months Sales Growth|alxoncology.com - Revenue Growth YoY (Last 12 Months)|CUE - Revenue Growth YoY (Last 12 Months)|PDSB - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Sonnet BioTherapeutics Holdings SONN|MAIA: Sales Growth YoY (TTM)|LIMN - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) LVTX|Sales Growth YoY (Last 12 Months) NXTC (NextCure)|Sales Growth YoY (Last Twelve Months) leaptx.com (LPTX)|INTS - Trailing Twelve Months Revenue Growth|Sales Growth YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Annual Revenue Growth (Last Twelve Months) Theriva Biologics, Inc. (TOVX)|GRTS: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) kinetabio.com KA|NEXI (neximmune.com) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Turnstone Biologics Corporation (TSBX)|Revenue Growth YoY (Last 12 Months) VCNX|HARP: Revenue Dynamics YoY (Last Twelve Months)